Alpha Tau Medical Ltd. is an Israeli clinical-stage oncology company specializing in the research, development, and commercialization of Alpha DaRT™ (Diffusing Alpha-emitters Radiation Therapy). This innovative technology delivers high-precision alpha radiation to treat solid tumors, aiming to be potent against the tumor while minimizing harm to surrounding healthy tissues. Alpha Tau is focused on advancing Alpha DaRT through clinical trials across various tumor types, with the ultimate goal of providing a new, effective treatment option for cancer patients globally.
The headquarters serves as the primary center for Alpha Tau Medical's research and development, global clinical trial oversight, manufacturing processes, strategic operations, and corporate administration.
Located within a kibbutz, the facility likely offers a unique, focused environment. It houses advanced laboratories and facilities essential for the development and production of its proprietary Alpha DaRT technology.
The work culture is characterized by innovation, scientific excellence, and a strong mission-driven focus on combating cancer. It fosters collaboration among a multidisciplinary team of scientists, engineers, clinicians, and corporate professionals.
This location is crucial as the origin and central hub for the development of the Alpha DaRT technology, coordinating all global efforts to bring this novel cancer therapy to patients.
Alpha Tau Medical has an expanding global footprint, driven by its international clinical trial program for Alpha DaRT. The company conducts studies in countries including Israel, the United States, Japan, Italy, Canada, and others. Operations are supported by its headquarters in Israel and regional offices in the USA and Japan, focusing on research collaborations, regulatory approvals, and strategic partnerships to make Alpha DaRT accessible worldwide.
Kibbutz Yakum
Yakum
Central District
Israel
Address: 2000 Commonwealth Ave, Suite 200, Newton, MA 02466
To facilitate the expansion of Alpha DaRT clinical programs and prepare for potential commercialization in the key U.S. healthcare market.
Address: PMO Nihonbashi Odenmacho 8F, 13-5 Nihonbashi Odenmacho, Chuo-ku, Tokyo 103-0011
To advance the Alpha DaRT technology in the Japanese market, known for its adoption of innovative medical treatments, and to conduct region-specific clinical trials.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Alpha Tau Medical' leadership includes:
Alpha Tau Medical has been backed by several prominent investors over the years, including:
Over the past year, Alpha Tau Medical strengthened its leadership team with the key appointment of Dr. Robert Den as Chief Medical Officer. No other major executive departures or hires have been publicly announced during this period.
Discover the tools Alpha Tau Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Alpha Tau Medical likely uses standardized corporate email formats. A common pattern observed for companies of similar size and structure is [first initial][last name]@[companydomain.com] or [first name].[last name]@[companydomain.com].
flast@alphatau.com (e.g., jdoe@alphatau.com)
Format
rden@alphatau.com
Example
70%
Success rate
GlobeNewswire • May 15, 2024
Alpha Tau Medical reported its financial results for the first quarter of 2024, providing updates on its ongoing clinical trials, including the ReSTART trial for recurrent Glioblastoma Multiforme (GBM), and its operational highlights. The company reiterated its commitment to advancing Alpha DaRT™ therapy....more
GlobeNewswire • January 24, 2024
Alpha Tau Medical announced a significant clinical milestone with the treatment of the first patient in its U.S. pivotal ReSTART trial. This study evaluates the safety and efficacy of Alpha DaRT™ for patients with recurrent glioblastoma multiforme (GBM), an aggressive form of brain cancer....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Alpha Tau Medical, are just a search away.